ABBOTT LABORATORIES (ABT) Fundamental Analysis & Valuation
NYSE:ABT • US0028241000
Current stock price
108.03 USD
-0.11 (-0.1%)
At close:
107.848 USD
-0.18 (-0.17%)
After Hours:
This ABT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ABT Profitability Analysis
1.1 Basic Checks
- ABT had positive earnings in the past year.
- In the past year ABT had a positive cash flow from operations.
- Each year in the past 5 years ABT has been profitable.
- In the past 5 years ABT always reported a positive cash flow from operatings.
1.2 Ratios
- ABT has a better Return On Assets (7.52%) than 87.50% of its industry peers.
- ABT has a better Return On Equity (12.51%) than 88.04% of its industry peers.
- ABT has a Return On Invested Capital of 9.17%. This is amongst the best in the industry. ABT outperforms 87.50% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for ABT is in line with the industry average of 9.18%.
- The 3 year average ROIC (8.63%) for ABT is below the current ROIC(9.17%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROIC | 9.17% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
1.3 Margins
- ABT's Profit Margin of 14.72% is amongst the best of the industry. ABT outperforms 90.76% of its industry peers.
- In the last couple of years the Profit Margin of ABT has grown nicely.
- ABT has a Operating Margin of 18.85%. This is amongst the best in the industry. ABT outperforms 90.22% of its industry peers.
- In the last couple of years the Operating Margin of ABT has grown nicely.
- ABT has a Gross Margin of 56.68%. This is comparable to the rest of the industry: ABT outperforms 57.07% of its industry peers.
- ABT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% |
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
2. ABT Health Analysis
2.1 Basic Checks
- ABT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- ABT has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, ABT has less shares outstanding
- The debt/assets ratio for ABT has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 5.02 indicates that ABT is not in any danger for bankruptcy at the moment.
- ABT has a better Altman-Z score (5.02) than 79.35% of its industry peers.
- ABT has a debt to FCF ratio of 1.75. This is a very positive value and a sign of high solvency as it would only need 1.75 years to pay back of all of its debts.
- ABT has a Debt to FCF ratio of 1.75. This is amongst the best in the industry. ABT outperforms 87.50% of its industry peers.
- A Debt/Equity ratio of 0.19 indicates that ABT is not too dependend on debt financing.
- The Debt to Equity ratio of ABT (0.19) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Altman-Z | 5.02 |
ROIC/WACC0.93
WACC9.89%
2.3 Liquidity
- A Current Ratio of 1.58 indicates that ABT should not have too much problems paying its short term obligations.
- ABT's Current ratio of 1.58 is on the low side compared to the rest of the industry. ABT is outperformed by 72.83% of its industry peers.
- ABT has a Quick Ratio of 1.18. This is a normal value and indicates that ABT is financially healthy and should not expect problems in meeting its short term obligations.
- ABT has a worse Quick ratio (1.18) than 69.57% of its industry peers.
- ABT does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 |
3. ABT Growth Analysis
3.1 Past
- ABT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
- Measured over the past 5 years, ABT shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
- ABT shows a small growth in Revenue. In the last year, the Revenue has grown by 5.67%.
- ABT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.08% yearly.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
3.2 Future
- The Earnings Per Share is expected to grow by 10.38% on average over the next years. This is quite good.
- ABT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.06% yearly.
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. ABT Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 20.98, ABT is valued on the expensive side.
- Based on the Price/Earnings ratio, ABT is valued a bit cheaper than the industry average as 79.35% of the companies are valued more expensively.
- ABT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 18.81, ABT is valued on the expensive side.
- 80.98% of the companies in the same industry are more expensive than ABT, based on the Price/Forward Earnings ratio.
- ABT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.84.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.98 | ||
| Fwd PE | 18.81 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ABT is valued a bit cheaper than 76.09% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABT indicates a rather cheap valuation: ABT is cheaper than 80.98% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.38 | ||
| EV/EBITDA | 16.69 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- ABT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.82
PEG (5Y)2.94
EPS Next 2Y10.76%
EPS Next 3Y10.34%
5. ABT Dividend Analysis
5.1 Amount
- ABT has a Yearly Dividend Yield of 2.33%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 0.22, ABT pays a better dividend. On top of this ABT pays more dividend than 96.74% of the companies listed in the same industry.
- ABT's Dividend Yield is a higher than the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.33% |
5.2 History
- On average, the dividend of ABT grows each year by 10.37%, which is quite nice.
- ABT has paid a dividend for at least 10 years, which is a reliable track record.
- ABT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.37%
Div Incr Years34
Div Non Decr Years34
5.3 Sustainability
- ABT pays out 63.09% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of ABT is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
ABT Fundamentals: All Metrics, Ratios and Statistics
108.03
-0.11 (-0.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/bmo
Earnings (Next)04-14 2026-04-14/bmo
Inst Owners81.83%
Inst Owner Change3.64%
Ins Owners0.47%
Ins Owner Change1.1%
Market Cap187.72B
Revenue(TTM)44.33B
Net Income(TTM)6.52B
Analysts80
Price Target136.02 (25.91%)
Short Float %0.99%
Short Ratio1.75
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.33% |
Yearly Dividend2.37
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years34
Div Non Decr Years34
Ex-Date04-15 2026-04-15 (0.63)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)0%
PT rev (3m)-7.35%
EPS NQ rev (1m)0.04%
EPS NQ rev (3m)-4.33%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.2%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.88%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.98 | ||
| Fwd PE | 18.81 | ||
| P/S | 4.23 | ||
| P/FCF | 25.38 | ||
| P/OCF | 19.62 | ||
| P/B | 3.6 | ||
| P/tB | 8.32 | ||
| EV/EBITDA | 16.69 |
EPS(TTM)5.15
EY4.77%
EPS(NY)5.74
Fwd EY5.32%
FCF(TTM)4.26
FCFY3.94%
OCF(TTM)5.51
OCFY5.1%
SpS25.51
BVpS30
TBVpS12.99
PEG (NY)1.82
PEG (5Y)2.94
Graham Number58.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROCE | 11.9% | ||
| ROIC | 9.17% | ||
| ROICexc | 10.51% | ||
| ROICexgc | 20.3% | ||
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% | ||
| FCFM | 16.68% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 69.67% | ||
| Cap/Sales | 4.9% | ||
| Interest Coverage | 15.33 | ||
| Cash Conversion | 83.39% | ||
| Profit Quality | 113.35% | ||
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 5.02 |
F-Score6
WACC9.89%
ROIC/WACC0.93
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%
EBIT growth 1Y18.75%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%
ABBOTT LABORATORIES / ABT Fundamental Analysis FAQ
What is the fundamental rating for ABT stock?
ChartMill assigns a fundamental rating of 7 / 10 to ABT.
What is the valuation status of ABBOTT LABORATORIES (ABT) stock?
ChartMill assigns a valuation rating of 5 / 10 to ABBOTT LABORATORIES (ABT). This can be considered as Fairly Valued.
What is the profitability of ABT stock?
ABBOTT LABORATORIES (ABT) has a profitability rating of 8 / 10.
What are the PE and PB ratios of ABBOTT LABORATORIES (ABT) stock?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABT) is 20.98 and the Price/Book (PB) ratio is 3.6.
Can you provide the expected EPS growth for ABT stock?
The Earnings per Share (EPS) of ABBOTT LABORATORIES (ABT) is expected to grow by 11.53% in the next year.